Remove tag shares
article thumbnail

STAT+: Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy

STAT

Kyowa Kirin is paying $16 per share — a nearly 100% premium on Orchard’s Wednesday closing price — in cash, amounting to roughly $390 million. LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in a $400 million deal, the companies said Thursday.

115
115
article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

Benefits of blockchain technology in the pharma supply chain Blockchain technology can address these issues in the pharmaceutical supply chain by providing timely data and increase shared data’s authenticity, integrity , and invariability. This can reduce the willingness for counterfeit and less accurate data, according to the review.

88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. Partly in response to such drugs, risk-sharing agreements (RSAs) have increased in popularity and aim to mitigate the risks of including high-cost drugs on reimbursement lists and healthcare plans.

FDA 105
article thumbnail

5 Ways Your Pharmacy Can Participate in Parkinson’s Awareness Month

Digital Pharmacist

Below we are sharing ways your pharmacy can learn more about how to participate in Parkinson’s Awareness Month. This year’s theme is the ABCs of PD, so they will be sharing an alphabet letter each day of the month with a different fact about Parkinson’s – your pharmacy can do this too if they would like!

article thumbnail

Oligonucleotide synthesis market to reach $16.7 billion by 2027

European Pharmaceutical Review

According to the report data, in 2021, antisense oligos accounted for the largest share of this segment, since many of these therapies are currently in clinical trials. Tag Copenhagen A/S (Denmark). CSBIO (US). Danaher Corporation (US). Eton Bioscience, Inc. (US). Eurofins Scientific (Germany). Ionis Pharmaceuticals, Inc. (US).

article thumbnail

Viseven at Reuters Pharma EU

Viseven

Reuters Pharma united the top pharma company representatives, providing them cozy and compact space to share the vision of the foreseeable future, exchange insights and experience, and possibly agree upon uniting their effort in customer service.

article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

The social media platform, which allows users to share short and often frivolous video clips, has a growing number of experts using it to communicate important information to a broad audience, and particular teenagers and young adults.